您的当前位置:首页 > 行业数据 > 阿布昔替尼的应答率及应答时间优于度普利尤单抗
图片属性
图片格式:PNG 图片大小:272KB 图片尺寸:1748*1316
同报告图片
 / 4
阿布昔替尼的应答率及应答时间优于度普利尤单抗_第1页
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
阿布昔替尼的应答率及应答时间优于度普利尤单抗_第2页
阿布昔替尼的应答率及应答时间优于度普利尤单抗_第3页
fCDlubTku70gfCDnlJ/nianliLbliYIgfCDlsI/liIblrZDoja/niakgfAp8LS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLS0tfAp8IDIwMTggfCAxICAgICAgICB8IDEgICAgICAgICAgfAp8IDIwMTkgfCAxICAgICAgICB8IDEgICAgICAgICAgfAp8IDIwMjAgfCAyICAgICAgICB8IDEgICAgICAgICAgfAp8IDIwMjEgfCAyICAgICAgICB8IDIgICAgICAgICAgfAp8IDIwMjIgfCAzICAgICAgICB8IDIgICAgICAgICAgfAp8IDIwMjNFfCA0ICAgICAgICB8IDMgICAgICAgICAgfAp8IDIwMjRFfCA1ICAgICAgICB8IDQgICAgICAgICAgfAp8IDIwMjVFfCA2ICAgICAgICB8IDUgICAgICAgICAgfAp8IDIwMjZFfCA4ICAgICAgICB8IDYgICAgICAgICAgfAp8IDIwMjdFfCAxMCAgICAgICB8IDcgICAgICAgICAgfAp8IDIwMjhFfCAxMiAgICAgICB8IDggICAgICAgICAgfAp8IDIwMjlFfCAxNSAgICAgICB8IDEwICAgICAgICAgfAp8IDIwMzBFfCAyMCAgICAgICB8IDE1ICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya6I2D5L+h55Sf54mp5oub6IKh5Lmm44CB5byX6Iul5pav54m55rKZ5Yip5paH5pWw5o2u77yM5Zu96IGU6K+B5Yi456CU56m25omA
阿布昔替尼的应答率及应答时间优于度普利尤单抗_第4页
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
阿布昔替尼的应答率及应答时间优于度普利尤单抗_第5页
所属报告: 泽璟制药-公司研究报告-新药步入商业化管线对外授权可期-241211(35页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠